methyl 2',3',4',5',6'-pentafluorobiphenyl-2-carboxylate | 1206164-15-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 2',3',4',5',6'-pentafluorobiphenyl-2-carboxylate
• 英文别名: Methyl 2-(2,3,4,5,6-pentafluorophenyl)benzoate
• CAS: 1206164-15-9
• 化学式: C₁₄H₇F₅O₂
• 分子量: 302.2
• InChiKey: JFZXTLOOJHVKCL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2-碘苯甲酸甲酯 、 2,3,4,5,6-五氟苯甲酸钾 在 copper(l) iodide 作用下， 以 二乙二醇二甲醚 为溶剂， 反应 24.0h， 以99%的产率得到methyl 2',3',4',5',6'-pentafluorobiphenyl-2-carboxylate
  参考文献：
  名称：

  多氟苯甲酸钾与芳基碘化物和溴化物的铜催化脱羧交叉偶联

  摘要：

  仅适用于铜：使用铜催化剂，易于获得且不挥发的多氟苯甲酸钾与芳基碘化物和溴化物的脱羧交叉偶联可提供极佳的收率的多氟联芳基和多氟苯磺酸酯（请参见方案）。报告了标题反应的机理分析。

  DOI：

  10.1002/anie.200904916

文献信息

• Highly efficient heterogeneous copper-catalyzed decarboxylative cross-coupling of potassium polyfluorobenzoates with aryl halides leading to polyfluorobiaryls
  作者：Yang Lin、Mingzhong Cai、Zhiqiang Fang、Hong Zhao

  DOI：10.1039/c7ra05711c

  日期：——

  reaction of potassium polyfluorobenzoates with aryl iodides and bromides was achieved in diglyme or DMAc at 130 or 160 °C in the presence of 10–20 mol% of a 1,10-phenanthroline-functionalized MCM-41-immobilized copper(I) complex, [MCM-41-Phen-CuI], yielding a variety of polyfluorobiaryls in good to excellent yields. This heterogeneous copper(I) complex could easily be prepared via a simple procedure

  多氟苯甲酸钾与芳基碘化物和溴化物的异质脱羧交叉偶联反应是在130或160°C的二甘醇二甲醚或DMAc中，在10–20 mol％的1,10-菲咯啉官能化的MCM-41固定化的情况下完成的铜（I）配合物[MCM-41-Phen-CuI]，可产生多种多氟联芳基化合物，收率好至极好。这种异质的铜（I）络合物可以通过简单的方法轻松地从市售易得的廉价试剂中制备，具有与均相CuI / Phen系统相同的催化活性，并且可以通过过滤反应溶液进行回收并循环至少8次。倍，而没有明显丧失催化活性。
• Novel aromatic azides for type I phototherapy
  申请人：Mallinckrodt Inc.

  公开号：US20020169107A1

  公开（公告）日：2002-11-14

  The present invention discloses novel aromatic azide derivatives and their bioconjugates for phototherapy of tumors and other lesions. The organic azides of the present invention are designed to absorb low-energy ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum. The phototherapeutic effect is caused by direct interaction of nitrene, the reactive intermediate produced upon photoexcitation of the aromatic azide, with the tissue of interest. The compounds of the present invention are administered to a patient, allowed to accumulate at the site of the tumor or other lesion, and are exposed to light in order to perform a phototherapeutic procedure.

  本发明公开了用于肿瘤和其他病变光疗的新型芳香族叠氮化物衍生物及其生物共轭物。本发明的有机叠氮化物可吸收电磁波谱中的低能量紫外线、可见光或近红外（NIR）区域。光疗效果是由芳香族叠氮化物光激发时产生的反应性中间体--腈与相关组织直接相互作用而产生的。给病人服用本发明的化合物，让其在肿瘤或其他病变部位积聚，并将其暴露在光下，以进行光治疗程序。
• DYE COMPOUNDS AS PHOTOACTIVE AGENTS
  申请人：Rajagopalan Raghavan

  公开号：US20080139786A1

  公开（公告）日：2008-06-12

  Novel azo, azide, and sulfenate photoactive compounds and methods using the compounds for photodiagnostic and/or phototherapeutic procedures. The compounds have the formula E-L-DYE-X—Y, wherein DYE is a photoactive component comprising a photoactive diagnostic agent, a photoactive type 1 agent, a photoactive type 2 agent, or a combination thereof; Y is a photoactive component comprising a photoactive type 1 agent, a photoactive type 2 agent, or a combination thereof; E is a targeting component for targeting the compound to an anatomical and/or physiological site of a patient; L is a linking component for linking E to DYE; and X is a linking component for linking DYE to Y.
• US8658433B2
  申请人：——

  公开号：US8658433B2

  公开（公告）日：2014-02-25